9 Publications
Glycated Serum Albumin and AGE Receptors.
Vetter, Stefan W
Advances in clinical chemistry, vol. 72, pp. 205-275, 2015. | Journal Article
RAGE overexpression confers a metastatic phenotype to the WM115 human primary melanoma cell line.
Meghnani, VarshaVetter, Stefan and Leclerc, Estelle
Biochimica et biophysica acta, vol. 1842, (no. 7), pp. 1017-27, 2014/Jul. | Journal Article
Phage display selection of peptides that target calcium-binding proteins.
Vetter, Stefan
Methods in molecular biology (Clifton, N.J.), vol. 963, pp. 215-35, 2013. | Journal Article
Interaction between glycated serum albumin and AGE-receptors depends on structural changes and the glycation reagent.
Indurthi, Venkata SLeclerc, Estelle and Vetter, Stefan
Archives of biochemistry and biophysics, vol. 528, (no. 2), pp. 185-96, 2012/Dec/15. | Journal Article
Moderate glycation of serum albumin affects folding, stability, and ligand binding.
Vetter, Stefan and Indurthi, Venkata S
Clinica chimica acta; international journal of clinical chemistry, vol. 412, (no. 23-24), pp. 2105-16, 2011/Nov/20. | Journal Article
The S100B/RAGE Axis in Alzheimer's Disease.
Leclerc, EstelleSturchler, Emmanuel and Vetter, Stefan
Cardiovascular psychiatry and neurology, vol. 2010, pp. 539581, 2010. | Journal Article
Binding of S100 proteins to RAGE: an update.
Leclerc, EstelleFritz, G√ľnterVetter, Stefan and Heizmann, Claus W
Biochimica et biophysica acta, vol. 1793, (no. 6), pp. 993-1007, 2009/Jun. | Journal Article
Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease.
Leclerc, EstelleSturchler, EmmanuelVetter, Stefan and Heizmann, Claus W
Reviews in the neurosciences, vol. 20, (no. 2), pp. 95-110, 2009. | Journal Article
RAGE and S100 protein transcription levels are highly variable in human melanoma tumors and cells.
Leclerc, EstelleHeizmann, Claus W and Vetter, Stefan
General physiology and biophysics, vol. 28 Spec No Focus, pp. F65-75, 2009. | Journal Article